S&P 500   3,617.83 (-0.56%)
DOW   29,567.43 (-1.15%)
QQQ   299.60 (+0.20%)
AAPL   120.55 (+3.40%)
MSFT   213.20 (-0.94%)
FB   276.04 (-0.64%)
GOOGL   1,756.64 (-1.70%)
AMZN   3,175.76 (-0.61%)
TSLA   584.30 (-0.25%)
NVDA   532.41 (+0.37%)
BABA   264.68 (-4.27%)
CGC   28.91 (-0.31%)
GE   10.23 (-1.63%)
MU   64.41 (+0.28%)
AMD   92.17 (+5.71%)
T   28.73 (-1.03%)
NIO   51.98 (-3.74%)
F   9.13 (+0.44%)
ACB   11.76 (+12.32%)
NFLX   489.42 (-0.39%)
BA   211.79 (-2.18%)
GILD   59.86 (-0.28%)
DIS   147.74 (+0.41%)
S&P 500   3,617.83 (-0.56%)
DOW   29,567.43 (-1.15%)
QQQ   299.60 (+0.20%)
AAPL   120.55 (+3.40%)
MSFT   213.20 (-0.94%)
FB   276.04 (-0.64%)
GOOGL   1,756.64 (-1.70%)
AMZN   3,175.76 (-0.61%)
TSLA   584.30 (-0.25%)
NVDA   532.41 (+0.37%)
BABA   264.68 (-4.27%)
CGC   28.91 (-0.31%)
GE   10.23 (-1.63%)
MU   64.41 (+0.28%)
AMD   92.17 (+5.71%)
T   28.73 (-1.03%)
NIO   51.98 (-3.74%)
F   9.13 (+0.44%)
ACB   11.76 (+12.32%)
NFLX   489.42 (-0.39%)
BA   211.79 (-2.18%)
GILD   59.86 (-0.28%)
DIS   147.74 (+0.41%)
S&P 500   3,617.83 (-0.56%)
DOW   29,567.43 (-1.15%)
QQQ   299.60 (+0.20%)
AAPL   120.55 (+3.40%)
MSFT   213.20 (-0.94%)
FB   276.04 (-0.64%)
GOOGL   1,756.64 (-1.70%)
AMZN   3,175.76 (-0.61%)
TSLA   584.30 (-0.25%)
NVDA   532.41 (+0.37%)
BABA   264.68 (-4.27%)
CGC   28.91 (-0.31%)
GE   10.23 (-1.63%)
MU   64.41 (+0.28%)
AMD   92.17 (+5.71%)
T   28.73 (-1.03%)
NIO   51.98 (-3.74%)
F   9.13 (+0.44%)
ACB   11.76 (+12.32%)
NFLX   489.42 (-0.39%)
BA   211.79 (-2.18%)
GILD   59.86 (-0.28%)
DIS   147.74 (+0.41%)
S&P 500   3,617.83 (-0.56%)
DOW   29,567.43 (-1.15%)
QQQ   299.60 (+0.20%)
AAPL   120.55 (+3.40%)
MSFT   213.20 (-0.94%)
FB   276.04 (-0.64%)
GOOGL   1,756.64 (-1.70%)
AMZN   3,175.76 (-0.61%)
TSLA   584.30 (-0.25%)
NVDA   532.41 (+0.37%)
BABA   264.68 (-4.27%)
CGC   28.91 (-0.31%)
GE   10.23 (-1.63%)
MU   64.41 (+0.28%)
AMD   92.17 (+5.71%)
T   28.73 (-1.03%)
NIO   51.98 (-3.74%)
F   9.13 (+0.44%)
ACB   11.76 (+12.32%)
NFLX   489.42 (-0.39%)
BA   211.79 (-2.18%)
GILD   59.86 (-0.28%)
DIS   147.74 (+0.41%)
Log in
NYSE:CHE

Chemed Stock Forecast, Price & News

$479.83
+6.38 (+1.35 %)
(As of 11/30/2020 03:02 PM ET)
Add
Compare
Today's Range
$474.08
Now: $479.83
$480.72
50-Day Range
$463.46
MA: $485.60
$508.59
52-Week Range
$330.01
Now: $479.83
$528.29
Volume1,885 shs
Average Volume96,216 shs
Market Capitalization$7.65 billion
P/E Ratio29.10
Dividend Yield0.29%
Beta0.61
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Read More
Chemed logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.09 out of 5 stars


Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690
Employees16,641

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.94 billion
Cash Flow$17.52 per share
Book Value$50.24 per share

Profitability

Net Income$219.92 million

Miscellaneous

Market Cap$7.65 billion
Next Earnings Date2/16/2021 (Estimated)
OptionableOptionable
$479.83
+6.38 (+1.35 %)
(As of 11/30/2020 03:02 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Chemed (NYSE:CHE) Frequently Asked Questions

How has Chemed's stock been impacted by Coronavirus (COVID-19)?

Chemed's stock was trading at $414.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CHE stock has increased by 15.7% and is now trading at $479.07.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Chemed?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Chemed
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Chemed?

Wall Street analysts have given Chemed a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Chemed wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Chemed's next earnings date?

Chemed is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Chemed
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) posted its earnings results on Thursday, October, 29th. The company reported $4.86 earnings per share for the quarter, beating analysts' consensus estimates of $3.97 by $0.89. The business had revenue of $528.30 million for the quarter, compared to the consensus estimate of $514.22 million. Chemed had a return on equity of 38.13% and a net margin of 13.11%. Chemed's revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter last year, the company posted $3.46 earnings per share.
View Chemed's earnings history
.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Friday, November 6th. Stockholders of record on Monday, November 16th will be given a dividend of $0.34 per share on Monday, December 7th. This represents a $1.36 annualized dividend and a yield of 0.28%. The ex-dividend date is Friday, November 13th.
View Chemed's dividend history
.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY20 earnings guidance on Thursday, October, 29th. The company provided earnings per share (EPS) guidance of $18.00-18.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $16.35.

What price target have analysts set for CHE?

2 Wall Street analysts have issued 12 month price targets for Chemed's shares. Their forecasts range from $535.00 to $535.00. On average, they expect Chemed's share price to reach $535.00 in the next year. This suggests a possible upside of 11.7% from the stock's current price.
View analysts' price targets for Chemed
.

Are investors shorting Chemed?

Chemed saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 168,500 shares, an increase of 22.5% from the September 30th total of 137,600 shares. Based on an average daily volume of 64,900 shares, the short-interest ratio is presently 2.6 days. Currently, 1.1% of the shares of the company are short sold.
View Chemed's Short Interest
.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), The Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), The Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

Who are Chemed's key executives?

Chemed's management team includes the following people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 66, Pay $4.86M)
  • Mr. David P. Williams, Exec. VP & CFO (Age 59, Pay $2.31M)
  • Mr. Spencer S. Lee, Exec. VP (Age 64, Pay $1.44M)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 41, Pay $1.79M)
  • Mr. Michael D. Witzeman CPA, MBA, VP & Controller (Age 49)
  • Ms. Lisa A. Reinhard, VP, Chief Admin. Officer & Assistant Sec.
  • Sherri Warner, Director of Investor Relations
  • Mr. Brian C. Judkins, VP, Sec. & Chief Legal Officer (Age 40)
  • Mr. Thomas C. Hutton, VP & Director (Age 69)

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by a number of retail and institutional investors. Top institutional investors include Alps Advisors Inc. (10.23%), BlackRock Inc. (9.16%), Neuberger Berman Group LLC (3.87%), Acadian Asset Management LLC (2.89%), Wells Fargo & Company MN (2.44%) and State Street Corp (2.37%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs.
View institutional ownership trends for Chemed
.

Which institutional investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Los Angeles Capital Management & Equity Research Inc., Boston Trust Walden Corp, First Trust Advisors LP, Allianz Asset Management GmbH, Acadian Asset Management LLC, Copeland Capital Management LLC, and Point72 Asset Management L.P.. Company insiders that have sold Chemed company stock in the last year include Andrea R Lindell, Donald E Saunders, Frank E Wood, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Patrick P Grace, and Spencer S Lee.
View insider buying and selling activity for Chemed
.

Which institutional investors are buying Chemed stock?

CHE stock was purchased by a variety of institutional investors in the last quarter, including Alps Advisors Inc., Assenagon Asset Management S.A., Kathmere Capital Management LLC, Great West Life Assurance Co. Can, North Point Portfolio Managers Corp OH, DekaBank Deutsche Girozentrale, AXA S.A., and Riverbridge Partners LLC.
View insider buying and selling activity for Chemed
.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $479.07.

How big of a company is Chemed?

Chemed has a market capitalization of $7.64 billion and generates $1.94 billion in revenue each year. The company earns $219.92 million in net income (profit) each year or $13.95 on an earnings per share basis. Chemed employs 16,641 workers across the globe.

What is Chemed's official website?

The official website for Chemed is www.chemed.com.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.